Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Neuronetics (STIM) Return on Sales (2017 - 2025)

Neuronetics (STIM) has disclosed Return on Sales for 9 consecutive years, with 0.25% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Sales rose 26.0% to 0.25% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.35%, a 13.0% increase, with the full-year FY2024 number at 0.56%, down 5.0% from a year prior.
  • Return on Sales was 0.25% for Q3 2025 at Neuronetics, up from 0.26% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.25% in Q3 2025 to a low of 0.78% in Q1 2022.
  • A 5-year average of 0.52% and a median of 0.51% in 2021 define the central range for Return on Sales.
  • Biggest YoY gain for Return on Sales was 39bps in 2021; the steepest drop was -33bps in 2021.
  • Neuronetics' Return on Sales stood at 0.55% in 2021, then grew by 12bps to 0.49% in 2022, then soared by 31bps to 0.33% in 2023, then tumbled by -77bps to 0.59% in 2024, then soared by 58bps to 0.25% in 2025.
  • Per Business Quant, the three most recent readings for STIM's Return on Sales are 0.25% (Q3 2025), 0.26% (Q2 2025), and 0.4% (Q1 2025).